Trial
NCT04293172
Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
AstraZeneca
Collaborators
IQVIA Pty Ltd
Condition
Sickle Cell Disease
Intervention
Brilinta
Why stopped
Study halted prematurely, prior to enrolment of first patient.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-07-15